Home Health & Hospice M&A Picks Up in November

by | Nov 18, 2015 8:00 am | Home Health & Hospice

Only halfway through the month, and November is already the year’s second-busiest month for M&A in the Home Health & Hospice sector. Six announced deals may not seem like a lot, but November’s total so far beats all but January 2015, which had 11 announcements (a few carried over from the fourth quarter, at that). Prices for three of the six November deals now total $108.7 million. Five of the six acquirers are publicly traded companies that have been buying throughout the year. We’ll have complete details on who’s buying what in our Health Care M&A Report, Fourth Quarter 2015. AcquirerTargetPrice LHC Group, Inc. Nurses Registry and Home Health Corp.$5.7... Read More »

Big Year for Billion-Dollar Health Care Deals

by | Nov 16, 2015 8:30 am | Healthcare Market Updates

The year isn’t over yet, but it’s time to gather some stats for our year-end issue. It’s already fair to say that there were more billion-dollar-plus health care transactions announced this year than at any time since we began keeping records, in 1995. So far, we’ve recorded 50 billion-dollar-plus transactions. Through November 13, their total is $333.3 billion. Even as busy as 2014 was for healthcare M&A (a record-breaker in deals and dollars), just 46 billion-dollar transactions were recorded, for a total of $325.2 billion. (Note: Beginning in Q3:12, only upfront payments were recorded as the price of the deal, without contingent payments. The data below has been adjusted accordingly... Read More »

Boston Scientific Buys Interventional Radiology Business

by | Nov 13, 2015 10:00 am | Medical Devices

The medical device sector just keeps plugging along with its mergers and acquisitions, with four announcements already in November. One was Boston Scientific Corporation (NYSE: BSX), which announced its acquisition of the interventional radiology business of CeloNova Biosciences, a global developer and manufacturer of endovascular and interventional cardiology technologies. The price was $70 million upfront, plus additional payments contingent on regulatory and sales milestones. BSX is taking on CeloNova’s Embozene Tandem Drug-Elutable Microspheres, which can be embedded with drugs used to treat liver cancer, and other oncology products. CeloNova has received an Investigational... Read More »

St. Michael’s Medical Center Saga Ends

by | Nov 13, 2015 8:00 am | Hospitals

Way back in December 2012, Prime Healthcare Services signed a letter of intent to acquire Trinity Health subsidiary, St. Michael’s Medical Center, then a 147-bed acute care hospital (down from 259 beds in 2010), in Newark, New Jersey. The parties signed a definitive agreement in February 2013. As usual, getting regulatory approval from the New Jersey Department of Health and the State Attorney General took a while. Too long, in fact. In April 2015, with the deal still not approved, a Navigant Consulting report suggested several healthcare facilities in the city be shut down or consolidated, which caused several campaigns and protests on St. Michael’s behalf. On August 10, 2015,... Read More »